Carlyle
Healthcare
Value Lens: Piramal Pharma stake comes at some discount but may almost lose that tag
Private equity firm Carlyle has agreed to buy a fifth of Piramal Enterprises Ltd’s pharmaceutical business at some discount but ......
Finance
PE volumes touch new low in January-June as coronavirus worsens sentiment
Private equity deal-making volumes in India fell sequentially further in the first half of 2020 to hit the lowest level ......
Healthcare
After three new India bets, Carlyle exits healthcare services firm
Private equity firm The Carlyle Group, which made three new India investments over the past two months, has fully exited ......
Healthcare
Metropolis Healthcare's deal to acquire Gujarat diagnostics firm collapses
Pathology chain Metropolis Healthcare Ltd’s plan to acquire a majority stake in a Gujarat-based diagnostics company has fallen through. Metropolis had, ......
Finance
With virus set to stretch exit period, a look at PE firms with oldest portfolios
The coronavirus pandemic has not only made private equity investors more cautious in deploying fresh capital but has also raised ......
Finance
Value Lens: How the Carlyle deal prices SeQuent over its overseas peers
The Carlyle Group’s deal to take control of SeQuent Scientific Ltd appears to have come at a premium for the ......
Healthcare
Ascent Capital tastes a lemon in exit from healthcare firm
Ascent Capital will fully exit a publicly listed animal healthcare company with token gains via a buyout deal, in yet ......
Finance
Private equity, distressed asset investors bucking the bleak hiring trend
The coronavirus pandemic may have battered the job market but many private investment firms in India are still looking to ......
Finance
Fund Scan: How Carlyle's focus on financials held it in good stead
It is not often that a private equity firm churns out nearly a billion dollars by exiting an investment in ......
Healthcare
Tracing Carlyle's returns as it cashes out most of its stake in healthcare firm
US-headquartered private equity giant The Carlyle Group has walked away with modest returns by selling a bulk of its stake ......